Fibrin degradation products in normal and abnormal pregnancy and parturition.
about
Clinical experience with brinaseSignificance of intravascular coagulation and fibrinolysis in acute hepatic failure.Stroke in pregnant and postpartum women.Coagulation disordersAn evaluation of the heat precipitation method for plasma fibrinogen estimation.Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity.Effect of intravenous prostaglandin E 2 on platelet function, coagulation, and fibrinolysisThe effect of age on the fibrinolytic enzyme system.Pancreatitis, multiple infarcts and oral contraception.Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies.Diffuse intravascular coagulation: an analysis of a basic mechanism of disease.Defining definitions: a Delphi study to develop a core outcome set for conditions of severe maternal morbidity.Conditions for collection of serum samples for the measurement of fibrin(ogen) degradation products by radioimmunoassay of fragment EThe effect of oxygen on the fibrinolytic enzyme system in vivo.The origin of fibrin breakdown products and the interpretation of their appearance in the circulationPost-partum haemorrhage and tranexamic acid: a global issue.Haemostatic mechanism in the uterine circulation during placental separation.Assessment of coagulation and fibrinolysis in pre-eclampsia.Coagulation changes during termination of pregnancy by prostaglandins and by vacuum aspiration.
P2860
Q24564485-DAA7D3C4-3DB3-471D-917E-4B07BFAD8C5AQ33466813-965110C9-4A68-4007-A030-A56B160C5A4BQ34024469-F9DFECC7-535A-4590-B7FE-A99BC2682F9DQ34302763-D9DBD49A-D9C1-4C0A-907C-16B98F26B34CQ36632977-6F9E1603-87C6-4D05-8232-C26E78117023Q36637755-63828410-76A0-4EA3-98DD-1D5E62EAB46AQ36649123-B71E4872-CFDD-42D9-9E9E-8487D9AECF90Q36659895-76C1E267-E2DC-4653-BDEE-2FBE2FAF08A4Q36811185-51552406-8645-4601-889A-200C1EBE68DEQ39636726-492AD19F-3A62-4051-AC7D-9FA9B8E48714Q39953445-3AA30678-6693-40A2-89A9-46865CA08AEDQ40103177-0B918B11-409F-410D-8D3E-2C0402209D56Q41243699-6F4E43E7-C092-4DED-84A6-B7778E197EF7Q41255291-FF1FD112-AAA5-4C5F-890C-625F8DF12306Q41256664-A0473D7D-A246-44BC-9871-82FC349929D3Q48273959-D55E8328-E770-43CE-ADCF-23A0FB50758AQ55128834-017E4C14-900D-4025-9774-4D9747FD5599Q55441141-47BB72F8-20E4-4A6A-A685-944F2E6478CDQ55509780-FE1DF8B0-2570-42E4-9B23-223689FF71DF
P2860
Fibrin degradation products in normal and abnormal pregnancy and parturition.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh-hant
name
Fibrin degradation products in normal and abnormal pregnancy and parturition.
@en
Fibrin degradation products in normal and abnormal pregnancy and parturition.
@nl
type
label
Fibrin degradation products in normal and abnormal pregnancy and parturition.
@en
Fibrin degradation products in normal and abnormal pregnancy and parturition.
@nl
prefLabel
Fibrin degradation products in normal and abnormal pregnancy and parturition.
@en
Fibrin degradation products in normal and abnormal pregnancy and parturition.
@nl
P2093
P2860
P356
P1433
P1476
Fibrin degradation products in normal and abnormal pregnancy and parturition.
@en
P2093
Davidson JF
Douglas AS
McNicol GP
Pidgeon CF
P2860
P304
P356
10.1136/BMJ.3.5663.137
P407
P577
1969-07-01T00:00:00Z